参考资料：

[1]Fraga CG, Croft KD, Kennedy DO, Tomás-Barberán FA. The effects of polyphenols and other bioactives on human health. Food Funct. 2019;10(2):514–28.

[2]Zhang S, Mao B, Cui S, Zhang Q, Zhao J, Tang X, et al. Absorption, metabolism, bioactivity, and biotransformation of epigallocatechin gallate. Crit Rev Food Sci Nutr. 2024;64(19):6546–66.

[3]Reygaert WC. Green tea catechins: Their use in treating and preventing infectious diseases. BioMed Res Int. 2018;2018:9105261.

[4]Chakrawarti L, Agrawal R, Dang S, Gupta S, Gabrani R. Therapeutic effects of EGCG: a patent review. Expert Opin Ther Pat. 2016;26(8):907–16.

[5]Talib WH, Awajan D, Alqudah A, Alsawwaf R, Althunibat R, Abu AlRoos M, et al. Targeting cancer hallmarks with Epigallocatechin Gallate (EGCG): mechanistic basis and therapeutic targets. Molecules. 2024;29(6):1373.

[6]Xiong, L.-G. et al. Epigallocatechin-3-gallate promotes healthy lifespan through mitohormesis during early-to-mid adulthood in Caenorhabditis elegans. Redox Biology 14, 305–315 (2017).

[7]Yuan, H. et al. The phytochemical epigallocatechin gallate prolongs the lifespan by improving lipid metabolism, reducing inflammation and oxidative stress in high‐fat diet‐fed obese rats. Aging Cell 19, (2020).

[8]Yuan, H. et al. The phytochemical epigallocatechin gallate prolongs the lifespan by improving lipid metabolism, reducing inflammation and oxidative stress in high‐fat diet‐fed obese rats. Aging Cell 19, (2020).

[9]Alam, M. et al. Epigallocatechin-3-gallate therapeutic potential in human diseases: molecular mechanisms and clinical studies. Molecular Biomedicine 5, (2024).

[10]Levin, J. et al. Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial. The Lancet Neurology 18, 724–735 (2019).

[11]Zhang, Y. et al. Green Tea and Epigallocatechin gallate (EGCG) for Cancer Prevention: A Systematic Review and Meta-Analysis. The American Journal of Chinese Medicine 53, 1755–1784 (2025).

[12]Zhao, H. et al. Efficacy of Epigallocatechin-3-Gallate in preventing dermatitis in patients with breast cancer receiving postoperative radiotherapy. JAMA Dermatology 158, 779 (2022).

[13]De Morais, A. C., Junior, Schincaglia, R. M., Passarelli, M., Pimentel, G. D. & Mota, J. F. Acute Epigallocatechin-3-Gallate Supplementation Alters Postprandial Lipids after a Fast-Food Meal in Healthy Young Women: A Randomized, Double-Blind, Placebo-Controlled Crossover Study. Nutrients 12, 2533 (2020).

[14]Forcano, L. et al. A multimodal lifestyle intervention complemented with epigallocatechin gallate to prevent cognitive decline in APOE- ɛ4 carriers with Subjective Cognitive Decline: a randomized, double-blinded clinical trial (PENSA study). The Journal of Prevention of Alzheimer S Disease 100271 (2025) doi:10.1016/j.tjpad.2025.100271.